Health News | Researchers Develop New MRI Tool to Detect, Track Progression of Cancer

Get latest articles and stories on Health at LatestLY. A team of researchers at the University of Waterloo recently developed a new magnetic resonance imaging (MRI) tool that makes cancerous tissue glow in medical images. It could help doctors more accurately detect and track the progression of cancer over time.

Representative image

Waterloo [Canada], March 21 (ANI): A team of researchers at the University of Waterloo recently developed a new magnetic resonance imaging (MRI) tool that makes cancerous tissue glow in medical images. It could help doctors more accurately detect and track the progression of cancer over time.

The innovation will be able to create images in which cancerous tissue appear to light up compared to healthy tissue, making it easier to see.

Also Read | COVID-19 Vaccine Update: NTAGI Asks Centre To Reduce Gap Between First and Second Dose of Covishield to 8-16 Weeks Due to Omicron.

The tool was developed as a part of a study, which was published in the journal 'Scientific Reports'.

"Our studies show this new technology has promising potential to improve cancer screening, prognosis and treatment planning," said Alexander Wong, Canada Research Chair in Artificial Intelligence and Medical Imaging and a professor of systems design engineering at Waterloo.

Also Read | Vicky Kaushal Shares Glimpse of His Sweaty Look Post-Workout and It's Too Hot! (View Pic).

Irregular packing of cells leads to differences in the way water molecules move in cancerous tissue compared to healthy tissue. The new technology, called synthetic correlated diffusion imaging, highlights these differences by capturing, synthesizing and mixing MRI signals at different gradient pulse strengths and timings.

In the largest study of its kind, the researchers collaborated with medical experts at the Lunenfeld-Tanenbaum Research Institute, several Toronto hospitals and the Ontario Institute for Cancer Research to apply the technology to a cohort of 200 patients with prostate cancer.

Compared to standard MRI techniques, synthetic correlated diffusion imaging was better at delineating significant cancerous tissue, making it a potentially powerful tool for doctors and radiologists.

"Prostate cancer is the second most common cancer in men worldwide and the most frequently diagnosed cancer among men in more developed countries," said Wong, also a director of the Vision and Image Processing (VIP) Lab at Waterloo. "That's why we targeted it first in our research.

"We also have very promising results for breast cancer screening, detection, and treatment planning. This could be a game-changer for many kinds of cancer imaging and clinical decision support," Wong added. (ANI)

(The above story is verified and authored by ANI staff, ANI is South Asia's leading multimedia news agency with over 100 bureaus in India, South Asia and across the globe. ANI brings the latest news on Politics and Current Affairs in India & around the World, Sports, Health, Fitness, Entertainment, & News. The views appearing in the above post do not reflect the opinions of LatestLY)

Share Now

Share Now